250 related articles for article (PubMed ID: 34505544)
21. Uric Acid and Neurocognitive Function in Survivors of Childhood Acute Lymphoblastic Leukemia Treated with Chemotherapy Only.
Cheung YT; Edelmann MN; Mulrooney DA; Green DM; Chemaitilly W; John N; Robison LL; Hudson MM; Krull KR
Cancer Epidemiol Biomarkers Prev; 2016 Aug; 25(8):1259-67. PubMed ID: 27345588
[TBL] [Abstract][Full Text] [Related]
22. Impaired exercise capacity and left ventricular function in long-term adult survivors of childhood acute lymphoblastic leukemia.
Christiansen JR; Kanellopoulos A; Lund MB; Massey R; Dalen H; Kiserud CE; Ruud E; Aakhus S
Pediatr Blood Cancer; 2015 Aug; 62(8):1437-43. PubMed ID: 25832752
[TBL] [Abstract][Full Text] [Related]
23. Possible roles of genetic variations in chemotherapy related cardiotoxicity in pediatric acute lymphoblastic leukemia and osteosarcoma.
Sági JC; Egyed B; Kelemen A; Kutszegi N; Hegyi M; Gézsi A; Herlitschke MA; Rzepiel A; Fodor LE; Ottóffy G; Kovács GT; Erdélyi DJ; Szalai C; Semsei ÁF
BMC Cancer; 2018 Jul; 18(1):704. PubMed ID: 29970035
[TBL] [Abstract][Full Text] [Related]
24. Echocardiographic evolution of left ventricular function in childhood leukemia survivors.
Aznar EGC; Casas AA; Escribano MÁCC; Montañés LJ; Aizpún JIL; Villagrasa PS
Curr Probl Cancer; 2018 Jul; 42(4):397-408. PubMed ID: 30166052
[TBL] [Abstract][Full Text] [Related]
25. Germline genetic variation in ETV6 and risk of childhood acute lymphoblastic leukaemia: a systematic genetic study.
Moriyama T; Metzger ML; Wu G; Nishii R; Qian M; Devidas M; Yang W; Cheng C; Cao X; Quinn E; Raimondi S; Gastier-Foster JM; Raetz E; Larsen E; Martin PL; Bowman WP; Winick N; Komada Y; Wang S; Edmonson M; Xu H; Mardis E; Fulton R; Pui CH; Mullighan C; Evans WE; Zhang J; Hunger SP; Relling MV; Nichols KE; Loh ML; Yang JJ
Lancet Oncol; 2015 Dec; 16(16):1659-66. PubMed ID: 26522332
[TBL] [Abstract][Full Text] [Related]
26. Dexrazoxane and Long-Term Heart Function in Survivors of Childhood Cancer.
Chow EJ; Aggarwal S; Doody DR; Aplenc R; Armenian SH; Baker KS; Bhatia S; Blythe N; Colan SD; Constine LS; Freyer DR; Kopp LM; Laverdière C; Leisenring WM; Sasaki N; Vrooman LM; Asselin BL; Schwartz CL; Lipshultz SE
J Clin Oncol; 2023 Apr; 41(12):2248-2257. PubMed ID: 36669148
[TBL] [Abstract][Full Text] [Related]
27. Late cardiotoxicity after low dose of anthracycline therapy for acute lymphoblastic leukemia in childhood.
Vandecruys E; Mondelaers V; De Wolf D; Benoit Y; Suys B
J Cancer Surviv; 2012 Mar; 6(1):95-101. PubMed ID: 21630046
[TBL] [Abstract][Full Text] [Related]
28. Deficit Accumulation Index and Biological Markers of Aging in Survivors of Childhood Cancer.
Williams AM; Mandelblatt JS; Wang M; Dong Q; Armstrong GT; Bhakta N; Brinkman TM; Ehrhardt MJ; Mulrooney DA; Gilmore N; Robison LL; Yasui Y; Small BJ; Srivastava D; Hudson MM; Ness KK; Krull KR; Wang Z
JAMA Netw Open; 2023 Nov; 6(11):e2344015. PubMed ID: 37983031
[TBL] [Abstract][Full Text] [Related]
29. Cumulative burden of cardiovascular morbidity in paediatric, adolescent, and young adult survivors of Hodgkin's lymphoma: an analysis from the St Jude Lifetime Cohort Study.
Bhakta N; Liu Q; Yeo F; Baassiri M; Ehrhardt MJ; Srivastava DK; Metzger ML; Krasin MJ; Ness KK; Hudson MM; Yasui Y; Robison LL
Lancet Oncol; 2016 Sep; 17(9):1325-34. PubMed ID: 27470081
[TBL] [Abstract][Full Text] [Related]
30. Are survivors of acute lymphoblastic leukemia (ALL) at increased risk of cardiovascular disease?
Oeffinger KC
Pediatr Blood Cancer; 2008 Feb; 50(2 Suppl):462-7; discussion 468. PubMed ID: 18064658
[TBL] [Abstract][Full Text] [Related]
31. Whole-exome sequencing of a rare case of familial childhood acute lymphoblastic leukemia reveals putative predisposing mutations in Fanconi anemia genes.
Spinella JF; Healy J; Saillour V; Richer C; Cassart P; Ouimet M; Sinnett D
BMC Cancer; 2015 Jul; 15():539. PubMed ID: 26201965
[TBL] [Abstract][Full Text] [Related]
32. Genes identified through genome-wide association studies of osteonecrosis in childhood acute lymphoblastic leukemia patients.
Gagné V; Aubry-Morin A; Plesa M; Abaji R; Petrykey K; St-Onge P; Beaulieu P; Laverdière C; Alos N; Leclerc JM; Sallan SE; Neuberg D; Kutok JL; Silverman LB; Sinnett D; Krajinovic M
Pharmacogenomics; 2019 Nov; 20(17):1189-1197. PubMed ID: 31686588
[No Abstract] [Full Text] [Related]
33. Cardiac autonomic dysfunction in survivors of childhood acute lymphoblastic leukemia: The St. Jude Lifetime Cohort Study.
Christoffersen L; Gibson TM; Pui CH; Joshi V; Partin RE; Green DM; Lanctot JQ; Howell CR; Mulrooney DA; Armstrong GT; Robison LL; Hudson MM; Ness KK
Pediatr Blood Cancer; 2020 Jul; 67(7):e28388. PubMed ID: 32383821
[TBL] [Abstract][Full Text] [Related]
34. Decreased adult height in survivors of childhood acute lymphoblastic leukemia: a report from the Childhood Cancer Survivor Study.
Chow EJ; Friedman DL; Yasui Y; Whitton JA; Stovall M; Robison LL; Sklar CA
J Pediatr; 2007 Apr; 150(4):370-5, 375.e1. PubMed ID: 17382112
[TBL] [Abstract][Full Text] [Related]
35. Reduced Morbidity and Mortality in Survivors of Childhood Acute Lymphoblastic Leukemia: A Report From the Childhood Cancer Survivor Study.
Dixon SB; Chen Y; Yasui Y; Pui CH; Hunger SP; Silverman LB; Ness KK; Green DM; Howell RM; Leisenring WM; Kadan-Lottick NS; Krull KR; Oeffinger KC; Neglia JP; Mertens AC; Hudson MM; Robison LL; Armstrong GT; Nathan PC
J Clin Oncol; 2020 Oct; 38(29):3418-3429. PubMed ID: 32706634
[TBL] [Abstract][Full Text] [Related]
36. Cardiovascular Testing Detects Underlying Dysfunction in Childhood Leukemia Survivors.
Long TM; Lee F; Lam K; Wallman KE; Walwyn TS; Choong CS; Naylor LH
Med Sci Sports Exerc; 2020 Mar; 52(3):525-534. PubMed ID: 31652239
[TBL] [Abstract][Full Text] [Related]
37. Anthracycline dose in childhood acute lymphoblastic leukemia: issues of early survival versus late cardiotoxicity.
Sorensen K; Levitt G; Bull C; Chessells J; Sullivan I
J Clin Oncol; 1997 Jan; 15(1):61-8. PubMed ID: 8996125
[TBL] [Abstract][Full Text] [Related]
38. Assessment of dexrazoxane as a cardioprotectant in doxorubicin-treated children with high-risk acute lymphoblastic leukaemia: long-term follow-up of a prospective, randomised, multicentre trial.
Lipshultz SE; Scully RE; Lipsitz SR; Sallan SE; Silverman LB; Miller TL; Barry EV; Asselin BL; Athale U; Clavell LA; Larsen E; Moghrabi A; Samson Y; Michon B; Schorin MA; Cohen HJ; Neuberg DS; Orav EJ; Colan SD
Lancet Oncol; 2010 Oct; 11(10):950-61. PubMed ID: 20850381
[TBL] [Abstract][Full Text] [Related]
39. Neurocognitive outcomes decades after treatment for childhood acute lymphoblastic leukemia: a report from the St Jude lifetime cohort study.
Krull KR; Brinkman TM; Li C; Armstrong GT; Ness KK; Srivastava DK; Gurney JG; Kimberg C; Krasin MJ; Pui CH; Robison LL; Hudson MM
J Clin Oncol; 2013 Dec; 31(35):4407-15. PubMed ID: 24190124
[TBL] [Abstract][Full Text] [Related]
40. Cardiovascular disease after childhood acute lymphoblastic leukaemia: a cohort study.
Hau EM; Caccia JN; Kasteler R; Spycher B; Suter T; Ammann RA; von der Weid NX; Kuehni CE
Swiss Med Wkly; 2019 Feb; 149():w20012. PubMed ID: 30852834
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
